Pablo
Irimia Sieira
Consultor Médico
Carlos
Rubio Terrés
Publications by the researcher in collaboration with Carlos Rubio Terrés (1)
2021
-
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 2, pp. 285-297